TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to demonstrate the safety and potential efficacy of
TJ-68 for improving muscle cramps in participants with ALS based on a two-site, randomized,
placebo-controlled double-blind multi-period crossover (N-of-1) study design.